IMAX ($IMAX) posted quarterly earnings results for Q1 2026 on Thursday, April 30th. The company reported earnings of $0.17 per share, beating estimates of $0.15 by $0.02. The company also reported revenue of $81,380,000, missing estimates of $81,885,171 by $-505,171.
You can see Quiver Quantitative's $IMAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IMAX Insider Trading Activity
IMAX insiders have traded $IMAX stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $IMAX stock by insiders over the last 6 months:
- KEVIN DOUGLAS has made 0 purchases and 6 sales selling 568,000 shares for an estimated $21,481,760.
- RICHARD L GELFOND (Chief Executive Officer) has made 0 purchases and 10 sales selling 486,284 shares for an estimated $18,580,296.
- MARK WELTON (President IMAX Global Theatres) has made 0 purchases and 2 sales selling 74,504 shares for an estimated $2,725,926.
- ROBERT D LISTER (Chief Legal Officer Sr Exec VP) sold 50,143 shares for an estimated $1,738,217
- CALAMERA PABLO (CTO & EVP) sold 20,586 shares for an estimated $704,566
- GIOVANNI M. DOLCI (Chief Commercial Officer & EVP) sold 6,188 shares for an estimated $211,909
- NATASHA FERNANDES (Chief Financial Officer & EVP) sold 2,652 shares for an estimated $95,864
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
IMAX Hedge Fund Activity
We have seen 122 institutional investors add shares of IMAX stock to their portfolio, and 112 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 4,657,865 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $172,154,690
- CONGRESS ASSET MANAGEMENT CO added 1,510,375 shares (+inf%) to their portfolio in Q1 2026, for an estimated $57,409,353
- CITADEL ADVISORS LLC removed 1,451,820 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $53,659,267
- JPMORGAN CHASE & CO removed 994,781 shares (-82.2%) from their portfolio in Q4 2025, for an estimated $36,767,105
- WALLEYE CAPITAL LLC added 944,122 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,894,749
- MIZUHO MARKETS AMERICAS LLC removed 784,139 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $28,981,777
- WESTFIELD CAPITAL MANAGEMENT CO LP added 723,861 shares (+44.6%) to their portfolio in Q4 2025, for an estimated $26,753,902
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
IMAX Analyst Ratings
Wall Street analysts have issued reports on $IMAX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Macquarie issued a "Outperform" rating on 01/15/2026
- Wells Fargo issued a "Overweight" rating on 12/18/2025
- JP Morgan issued a "Overweight" rating on 12/15/2025
To track analyst ratings and price targets for IMAX, check out Quiver Quantitative's $IMAX forecast page.
IMAX Price Targets
Multiple analysts have issued price targets for $IMAX recently. We have seen 9 analysts offer price targets for $IMAX in the last 6 months, with a median target of $45.0.
Here are some recent targets:
- Alicia Reese from Wedbush set a target price of $46.0 on 04/23/2026
- Steve Frankel from Rosenblatt set a target price of $47.0 on 04/20/2026
- David Joyce from Seaport Global set a target price of $45.0 on 04/08/2026
- Mike Burton from Goldman Sachs set a target price of $41.0 on 03/02/2026
- Mike Hickey from Benchmark set a target price of $44.0 on 02/26/2026
- Chad Beynon from Macquarie set a target price of $45.0 on 02/26/2026
- David Karnovsky from JP Morgan set a target price of $48.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
